InsightfulValue
โ† Home

Roche
Roche

+598.07%

Pharma / Pharmaceuticals and Healthcare


๐Ÿ”ง Tools

โœ… Due Diligence
Company at a Glance

More reviews (1)
Roche

๐Ÿ“Š Get full analytics about Roche

Sign up for free or log in

๐Ÿ“– Get insights from "The Checklist Value Investor โ€” A Smarter Way to Pick Stocks" now!

Price
Live  
Infographic
Infographics
Overview
Roche is a Swiss multinational healthcare company that operates globally, with its headquarters in Basel, Switzerland. The company was founded in 1896 by Fritz Hoffmann-La Roche and is today one of the largest pharmaceutical companies in the world, with a focus on developing and manufacturing innovative medicines and diagnostics for improving people's health and quality of life.
Roche is divided into two main divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals division focuses on developing drugs and therapies for a wide range of diseases, including cancer, infectious diseases, and autoimmune disorders. The Diagnostics division specializes in providing diagnostic solutions for early detection, prevention, diagnosis, and management of diseases.
In addition to its core areas of pharmaceuticals and diagnostics, Roche also has a strong presence in the fields of oncology, neurology, immunology, and virology. The company's portfolio includes well-known brands such as Avastin, Herceptin, Rituxan, and Tamiflu.
Roche has a global workforce of over 98,000 employees, with operations in more than 100 countries. The company invests heavily in research and development, with over 16 billion Swiss francs invested in 2020 alone.
Roche is committed to sustainability and social responsibility, taking into account environmental, social, and economic aspects in all of its operations. The company has received numerous awards and recognition for its initiatives in these areas, including being named as one of the world's most sustainable companies by the Dow Jones Sustainability Indices.
In addition to its focus on healthcare, Roche is also involved in various philanthropic and humanitarian efforts, such as providing access to healthcare for underserved communities, supporting education and research, and investing in sustainable healthcare infrastructure in developing countries.
How to explain to a 10 year old kid about the company?
Roche

๐Ÿ“ˆ Want to read more about Roche?

Sign up for free or log in

๐Ÿ’ก Learn smarter stock picks with "The Checklist Value Investor โ€” A Smarter Way to Pick Stocks"

Um9jaGUgaX MgYSBiaWcg Y29tcGFueS B0aGF0IHdv cmtzIGluIG hlYWx0aCBh bmQgbWVkaW NpbmUuIFRo ZXkgY3JlYX RlIGltcG9y dGFudCB0b2 9scyBhbmQg bWVkaWNpbm VzIHRoYXQg aGVscCBkb2 N0b3JzIGFu ZCBob3NwaX RhbHMgdGFr ZSBjYXJlIG 9mIHNpY2sg cGVvcGxlLi BJbWFnaW5l IGlmIHNvbW VvbmUgaGFz IGEgYmFkIG NvbGQgb3Ig c29tZXRoaW 5nIG1vcmUg c2VyaW91cy BsaWtlIGNh bmNlci4gUm 9jaGUgbWFr ZXMgdGVzdH MgdG8gZmln dXJlIG91dC B3aGF0IGlz IHdyb25nLC BhbmQgdGhl eSBhbHNvIG 1ha2UgbWVk aWNpbmVzIH RvIGhlbHAg cGVvcGxlIG ZlZWwgYmV0 dGVyLjxicj 5Sb2NoZSBt YWtlcyBtb2 5leSBieSBz ZWxsaW5nIH RoZXNlIHRl c3RzIGFuZC BtZWRpY2lu ZXMuIFdoZW 4gZG9jdG9y cyBuZWVkIH RvIGZpbmQg b3V0IHdoYX QgaXMgbWFr aW5nIHNvbW VvbmUgc2lj aywgdGhleS BidXkgdGhl IHRlc3RzIG Zyb20gUm9j aGUsIGFuZC B3aGVuIHRo ZXkgbmVlZC B0byB0cmVh dCBwYXRpZW 50cywgdGhl eSBvcmRlci B0aGUgbWVk aWNpbmVzLi BCZWNhdXNl IHRoZXkgaG VscCBzYXZl IGxpdmVzIG FuZCBtYWtl IHBlb3BsZS BoZWFsdGhp ZXIsIG1hbn kgaG9zcGl0 YWxzIGFuZC Bkb2N0b3Jz IHRydXN0IG FuZCBjaG9v c2UgUm9jaG XigJlzIHBy b2R1Y3RzLj xicj5Sb2No ZSBpcyBzdW NjZXNzZnVs IGZvciBhIG ZldyByZWFz b25zLiBGaX JzdCwgdGhl eSBpbnZlc3 QgYSBsb3Qg b2YgdGltZS BhbmQgbW9u ZXkgaW50by ByZXNlYXJj aCB0byBmaW 5kIG5ldyB3 YXlzIHRvIH RyZWF0IGRp c2Vhc2VzLC BtYWtpbmcg dGhlbSBhIG xlYWRlciBp biBzY2llbm NlIGFuZCBt ZWRpY2luZS 4gVGhleSBh bHNvIHdvcm sgd2l0aCBz Y2llbnRpc3 RzIGFuZCBy ZXNlYXJjaG VycyB0byBr ZWVwIGNvbW luZyB1cCB3 aXRoIGJldH RlciB0cmVh dG1lbnRzLi BTZWNvbmQs IHRoZXkgbW FrZSBzdXJl IHRoZWlyIH Byb2R1Y3Rz IGFyZSB2ZX J5IGhpZ2gg cXVhbGl0eS wgd2hpY2gg bWVhbnMgZG 9jdG9ycyBh bmQgaG9zcG l0YWxzIGNh biByZWx5IG 9uIHRoZW0u IExhc3RseS wgbWFueSBw ZW9wbGUgYX JlIGdldHRp bmcgb2xkZX IgYW5kIHRo ZXJlIGFyZS BuZXcgZGlz ZWFzZXMsIH NvIHRoZSBu ZWVkIGZvci BuZXcgbWVk aWNpbmVzIG FuZCB0ZXN0 cyBpcyBncm 93aW5nLiBS b2NoZSBpcy ByZWFkeSB0 byBtZWV0IH RoaXMgZGVt YW5kLCB3aG ljaCBoZWxw cyB0aGVtIG NvbnRpbnVl IHRvIGJlIH N1Y2Nlc3Nm dWwgaW4gdG hlIGZ1dHVy ZS48YnI+
What is special about the company?
Roche

๐Ÿ“ˆ Want to read more about Roche?

Sign up for free or log in

โœ… Download "The Checklist Value Investor โ€” A Smarter Way to Pick Stocks" โ€” totally free!

MS4gUGlvbm VlcmluZyBI ZWFsdGhjYX JlIElubm92 YXRpb25zOi BSb2NoZSBo YXMgYSBsb2 5nIGhpc3Rv cnkgb2YgcG lvbmVlcmlu ZyBicmVha3 Rocm91Z2gg dHJlYXRtZW 50cyBmb3Ig ZGlzZWFzZX MgbGlrZSBj YW5jZXIsIG 11bHRpcGxl IHNjbGVyb3 NpcywgYW5k IEhJVi9BSU RTLiBUaGUg Y29tcGFueS BoYXMgYWxz byBiZWVuIG F0IHRoZSBm b3JlZnJvbn Qgb2YgZGV2 ZWxvcGluZy BkaWFnbm9z dGljIHRlc3 RzIGFuZCBw ZXJzb25hbG l6ZWQgbWVk aWNpbmUgdG 8gaW1wcm92 ZSBwYXRpZW 50IG91dGNv bWVzLjxicj 4yLiBHbG9i YWwgUHJlc2 VuY2U6IFJv Y2hlIGlzIG EgdHJ1bHkg aW50ZXJuYX Rpb25hbCBj b21wYW55LC B3aXRoIGEg cHJlc2VuY2 UgaW4gb3Zl ciAxMDAgY2 91bnRyaWVz IHdvcmxkd2 lkZS4gSXQg aXMgY29uc2 lzdGVudGx5 IHJhbmtlZC BhcyBvbmUg b2YgdGhlIH RvcCBwaGFy bWFjZXV0aW NhbCBjb21w YW5pZXMgaW 4gdGhlIHdv cmxkIGFuZC BoYXMgYSBz dHJvbmcgcH Jlc2VuY2Ug aW4gYm90aC BkZXZlbG9w ZWQgYW5kIG VtZXJnaW5n IG1hcmtldH MuPGJyPjMu IFN0cm9uZy BSZXNlYXJj aCBhbmQgRG V2ZWxvcG1l bnQ6IFJvY2 hlIGludmVz dHMgaGVhdm lseSBpbiBy ZXNlYXJjaC BhbmQgZGV2 ZWxvcG1lbn QsIHdpdGgg YSBmb2N1cy BvbiB0cmFu c2xhdGluZy BzY2llbnRp ZmljIGRpc2 NvdmVyaWVz IGludG8gaW 5ub3ZhdGl2 ZSB0cmVhdG 1lbnRzIGFu ZCBkaWFnbm 9zdGljIHRv b2xzLiBJbi AyMDE5LCB0 aGUgY29tcG FueSBpbnZl c3RlZCBvdm VyIDExIGJp bGxpb24gU3 dpc3MgZnJh bmNzIChhcH Byb3hpbWF0 ZWx5ICQxMS 4zIGJpbGxp b24gVVNEKS BpbiBSJkQu PGJyPjQuIE NvbW1pdG1l bnQgdG8gU3 VzdGFpbmFi aWxpdHk6IF JvY2hlIGlz IGNvbW1pdH RlZCB0byBz dXN0YWluYW JsZSBidXNp bmVzcyBwcm FjdGljZXMg YW5kIGhhcy BzZXQgYW1i aXRpb3VzIG dvYWxzIHRv IHJlZHVjZS BpdHMgZW52 aXJvbm1lbn RhbCBpbXBh Y3QgYW5kIH Byb21vdGUg c29jaWFsIH Jlc3BvbnNp YmlsaXR5Li BUaGUgY29t cGFueSBoYX MgYmVlbiBy ZWNvZ25pem VkIGZvciBp dHMgZWZmb3 J0cyBpbiBz dXN0YWluYW JpbGl0eSwg aW5jbHVkaW 5nIGJlaW5n IG5hbWVkIG 9uZSBvZiB0 aGUgd29ybG QncyBtb3N0 IHN1c3RhaW 5hYmxlIGNv bXBhbmllcy BieSB0aGUg RG93IEpvbm VzIFN1c3Rh aW5hYmlsaX R5IEluZGlj ZXMuPGJyPj UuIENvbGxh Ym9yYXRpdm UgUGFydG5l cnNoaXBzOi BSb2NoZSB2 YWx1ZXMgcG FydG5lcnNo aXBzIGFuZC Bjb2xsYWJv cmF0aW9ucy B3aXRoIG90 aGVyIGNvbX Bhbmllcywg YWNhZGVtaW MgaW5zdGl0 dXRpb25zLC BhbmQgaGVh bHRoY2FyZS Bvcmdhbml6 YXRpb25zLi BUaGlzIGFw cHJvYWNoIG FsbG93cyB0 aGUgY29tcG FueSB0byBh Y2Nlc3Mgbm V3IHRlY2hu b2xvZ2llcy BhbmQgZXhw ZXJ0aXNlIG FuZCBhY2Nl bGVyYXRlIH RoZSBkZXZl bG9wbWVudC BvZiBpbm5v dmF0aXZlIH RyZWF0bWVu dHMuPGJyPj YuIFN0cm9u ZyBQb3J0Zm 9saW8gb2Yg UHJvZHVjdH M6IFJvY2hl IGhhcyBhIG RpdmVyc2Ug cG9ydGZvbG lvIG9mIHBy b2R1Y3RzLC BpbmNsdWRp bmcgYmlvbG 9naWMgYW5k IHNtYWxsIG 1vbGVjdWxl IG1lZGljaW 5lcywgZGlh Z25vc3RpYy B0ZXN0cywg YW5kIHJlc2 VhcmNoIGFu ZCBkZXZlbG 9wbWVudCBz ZXJ2aWNlcy 4gVGhpcyBh bGxvd3MgdG hlIGNvbXBh bnkgdG8gc2 VydmUgYSB3 aWRlIHJhbm dlIG9mIGRp c2Vhc2UgYX JlYXMgYW5k IHBhdGllbn QgcG9wdWxh dGlvbnMuPG JyPjcuIENv bW1pdG1lbn QgdG8gRXRo aWNzIGFuZC BDb21wbGlh bmNlOiBSb2 NoZSBoYXMg YSBzdHJvbm cgY29tbWl0 bWVudCB0by BldGhpY2Fs IGJ1c2luZX NzIHByYWN0 aWNlcyBhbm QgY29tcGxp YW5jZSB3aX RoIGxhd3Mg YW5kIHJlZ3 VsYXRpb25z LiBUaGUgY2 9tcGFueSBo YXMgYSBjb2 1wcmVoZW5z aXZlIGNvZG Ugb2YgY29u ZHVjdCBhbm QgdHJhaW5z IGFsbCBlbX Bsb3llZXMg b24gZXRoaW NhbCBzdGFu ZGFyZHMgYW 5kIGNvbXBs aWFuY2UgcG 9saWNpZXMu PGJyPjguIE VtcGhhc2lz IG9uIEVtcG xveWVlIERl dmVsb3BtZW 50OiBSb2No ZSByZWNvZ2 5pemVzIHRo ZSBpbXBvcn RhbmNlIG9m IGludmVzdG luZyBpbiBp dHMgZW1wbG 95ZWVzIGFu ZCBmb3N0ZX JpbmcgYSBj dWx0dXJlIG 9mIGlubm92 YXRpb24sIG RpdmVyc2l0 eSwgYW5kIG luY2x1c2lv bi4gVGhlIG NvbXBhbnkg b2ZmZXJzIG EgdmFyaWV0 eSBvZiB0cm FpbmluZyBh bmQgZGV2ZW xvcG1lbnQg cHJvZ3JhbX MgYW5kIGhh cyBiZWVuIH JlY29nbml6 ZWQgYXMgb2 5lIG9mIHRo ZSBiZXN0IG NvbXBhbmll cyB0byB3b3 JrIGZvciBp biBudW1lcm 91cyBjb3Vu dHJpZXMuPG JyPjkuIFBh dGllbnQtQ2 VudHJpYyBB cHByb2FjaD ogUm9jaGUg cHV0cyBwYX RpZW50cyBh dCB0aGUgY2 VudGVyIG9m IGV2ZXJ5dG hpbmcgdGhl eSBkbyBhbm Qgd29ya3Mg Y2xvc2VseS B3aXRoIGhl YWx0aGNhcm UgcHJvdmlk ZXJzIGFuZC BwYXRpZW50 IG9yZ2FuaX phdGlvbnMg dG8gZW5zdX JlIHRoYXQg dGhlaXIgdH JlYXRtZW50 cyBhbmQgc2 VydmljZXMg bWVldCB0aG UgbmVlZHMg b2YgcGF0aW VudHMuPGJy PjEwLiBMb2 5nLVRlcm0g VmlzaW9uOi BSb2NoZSBo YXMgYSBsb2 5nLXRlcm0g dmlzaW9uIG ZvciBzdXN0 YWluYWJsZS Bncm93dGgg YW5kIGlzIG NvbW1pdHRl ZCB0byBtYW tpbmcgYSBw b3NpdGl2ZS BpbXBhY3Qg b24gc29jaW V0eS4gVGhl IGNvbXBhbn kncyBtaXNz aW9uLCAiRG 9pbmcgbm93 IHdoYXQgcG F0aWVudHMg bmVlZCBuZX h0LCIgcmVm bGVjdHMgaX RzIGRlZGlj YXRpb24gdG 8gY29uc3Rh bnRseSBwdX NoaW5nIHRo ZSBib3VuZG FyaWVzIG9m IGhlYWx0aG NhcmUgdG8g aW1wcm92ZS BwYXRpZW50 IG91dGNvbW VzLg==
What the company's business model?
Roche

๐Ÿ“ˆ Want to read more about Roche?

Sign up for free or log in

๐ŸŽ Free download! "The Checklist Value Investor โ€” A Smarter Way to Pick Stocks"

VGhlIFJvY2 hlIGNvbXBh bnkgaXMgYS BnbG9iYWwg aGVhbHRoY2 FyZSBjb21w YW55IHRoYX QgZm9jdXNl cyBvbiBwaG FybWFjZXV0 aWNhbHMgYW 5kIGRpYWdu b3N0aWNzLi BUaGVpciBi dXNpbmVzcy Btb2RlbCBp cyB0byBkZX ZlbG9wLCBt YW51ZmFjdH VyZSwgYW5k IG1hcmtldC Bpbm5vdmF0 aXZlIG1lZG ljaW5lcyBh bmQgZGlhZ2 5vc3RpYyB0 ZXN0cyB0aG F0IGNhbiBo ZWxwIHBhdG llbnRzIGJl dHRlciBtYW 5hZ2UgYW5k IHRyZWF0IG Egd2lkZSBy YW5nZSBvZi BkaXNlYXNl cyBhbmQgbW VkaWNhbCBj b25kaXRpb2 5zLjxicj5S b2NoZSdzIG J1c2luZXNz IG1vZGVsIG lzIGJ1aWx0 IGFyb3VuZC B0aGVpciBj b21taXRtZW 50IHRvIHJl c2VhcmNoIG FuZCBkZXZl bG9wbWVudC wgd2l0aCBz aWduaWZpY2 FudCBpbnZl c3RtZW50cy BpbiBib3Ro IGZpZWxkcy 4gVGhlIGNv bXBhbnkgaG FzIGEgZGl2 ZXJzZSBwb3 J0Zm9saW8g b2YgcHJvZH VjdHMgdGhh dCBpbmNsdW RlcyBwcmVz Y3JpcHRpb2 4gbWVkaWNp bmVzLCBkaW Fnbm9zdGlj IHRlc3RzLC BhbmQgc29s dXRpb25zIG ZvciBwZXJz b25hbGl6ZW QgaGVhbHRo Y2FyZS48Yn I+Um9jaGUn cyBrZXkgc3 RyYXRlZ2ll cyBpbmNsdW RlIGZvY3Vz aW5nIG9uIG FyZWFzIG9m IGhpZ2ggdW 5tZXQgbWVk aWNhbCBuZW VkLCBjb2xs YWJvcmF0aW 5nIHdpdGgg ZXh0ZXJuYW wgcGFydG5l cnMgdG8gbG V2ZXJhZ2Ug dGhlaXIgZX hwZXJ0aXNl LCBhbmQgaW 52ZXN0aW5n IGluIHRoZS BkZXZlbG9w bWVudCBvZi BuZXcgYW5k IHByb21pc2 luZyB0ZWNo bm9sb2dpZX MuPGJyPklu IGFkZGl0aW 9uLCBSb2No ZSBoYXMgYS BzdHJvbmcg cHJlc2VuY2 UgaW4gZW1l cmdpbmcgbW Fya2V0cywg bWFraW5nIH RoZWlyIHBy b2R1Y3RzIG FjY2Vzc2li bGUgdG8gYS BsYXJnZXIg cG9wdWxhdG lvbi4gVGhl IGNvbXBhbn kgYWxzbyBw cmlvcml0aX plcyBzdXN0 YWluYWJpbG l0eSBhbmQg Y29ycG9yYX RlIHJlc3Bv bnNpYmlsaX R5LCBhaW1p bmcgdG8gbW FrZSBhIHBv c2l0aXZlIG ltcGFjdCBv biBzb2NpZX R5Ljxicj5P dmVyYWxsLC BSb2NoZSdz IGJ1c2luZX NzIG1vZGVs IGlzIGRyaX ZlbiBieSB0 aGVpciBtaX NzaW9uIHRv IGltcHJvdm UgdGhlIGxp dmVzIG9mIH BhdGllbnRz IHdvcmxkd2 lkZSB0aHJv dWdoIHRoZW lyIGlubm92 YXRpdmUgaG VhbHRoY2Fy ZSBzb2x1dG lvbnMu
Is AI a threat?
AI does have the potential to pose a material threat to Rocheโ€™s products, services, and competitive positioning in several ways.
1. Substitution: AI can enhance or replace certain diagnostic and therapeutic processes. For example, AI algorithms are increasingly being used in diagnostics to interpret imaging results or analyze genetic data, which could compete with Rocheโ€™s existing products in personalized medicine and diagnostics. If other companies develop AI-driven solutions that provide faster or more accurate results, Roche could face challenges in maintaining its market share.
2. Disintermediation: AI technologies can enable direct-to-consumer models, allowing patients to access personalized health insights and treatments without going through traditional healthcare providers or pharmaceutical companies. This could disrupt Rocheโ€™s traditional business model, particularly in diagnostics and therapeutic services where intermediaries play a significant role.
3. Margin Pressure: The integration of AI in healthcare can lead to increased competition, as new entrants might use AI to reduce operational costs and improve efficiency. As a result, Roche could face price pressure on its products and services. Companies leveraging AI may be able to offer similar solutions at lower prices, making it more challenging for Roche to maintain its profit margins.
Overall, while AI holds the potential to enhance healthcare, it also introduces vulnerabilities for Roche that could impact its competitive positioning and profitability in various markets. Roche will need to adapt and innovate to leverage AI effectively, while also addressing the competitive threats it presents.
Sensitivity to interest rates
The sensitivity of Rocheโ€™s earnings, cash flow, and valuation to changes in interest rates can be analyzed through several key factors:
1. Earnings Sensitivity: Roche, as a pharmaceutical company, generates revenue primarily from the sale of drugs and diagnostics. While its sales might not be directly affected by interest rates, the companyโ€™s earnings could be impacted by the cost of capital. If interest rates rise, financing costs increase, potentially reducing profit margins, especially if the company relies on debt to fund operations or R&D.
2. Cash Flow Sensitivity: Rocheโ€™s cash flow is influenced by operational performance and capital structure. Higher interest rates can lead to increased interest expenses on existing debt, which can constrain cash flow available for reinvestment or dividends. Moreover, if higher rates slow economic growth, it could affect revenue-generating activities, further impacting cash flow.
3. Valuation Sensitivity: Valuation models, such as discounted cash flow (DCF), are sensitive to changes in interest rates. A rising interest rate environment typically leads to a higher discount rate applied to future cash flows, which can result in lower present values and, consequently, a lower valuation for Roche. Investors often adjust their required rates of return based on prevailing interest rates, which can further influence Rocheโ€™s stock price.
In summary, while Rocheโ€™s core operations may not be directly tied to interest rate fluctuations, the broader financial implicationsโ€”such as costs of capital, cash flow dynamics, and valuation methodsโ€”can make the companyโ€™s financial performance somewhat sensitive to interest rate changes. An increase in rates can lead to higher costs, reduced cash flow, and a downward pressure on valuation. Conversely, lower interest rates could provide a beneficial environment for earnings growth, cash flow expansion, and improved valuations.
Resilience to the future changes
Roche

๐Ÿ“ˆ Want to read more about Roche?

Sign up for free or log in

๐Ÿ“ฅ Get our free eBook now: "The Checklist Value Investor โ€” A Smarter Way to Pick Stocks"

QSByZWFsaX N0aWMgc2Nl bmFyaW8gdG hhdCBjb3Vs ZCBwZXJtYW 5lbnRseSBp bXBhaXIgUm 9jaGXigJlz IGVjb25vbW ljcyBvdmVy IHRoZSBuZX h0IDPigJM1 IHllYXJzIG lzIHRoZSBs b3NzIG9mIH BhdGVudCBw cm90ZWN0aW 9uIG9uIGtl eSBibG9ja2 J1c3RlciBk cnVncywgY2 9tYmluZWQg d2l0aCBhIH NpZ25pZmlj YW50IGluY3 JlYXNlIGlu IGNvbXBldG l0aW9uIGZy b20gYmlvc2 ltaWxhcnMg YW5kIGdlbm VyaWNzLiA8 YnI+SWYgUm 9jaGXigJlz IGZsYWdzaG lwIHByb2R1 Y3RzLCBsaW tlIGl0cyBj YW5jZXIgbW VkaWNhdGlv bnMgYW5kIG 90aGVyIHNw ZWNpYWx0eS BwaGFybWFj ZXV0aWNhbH MsIHdlcmUg dG8gbG9zZS BwYXRlbnQg ZXhjbHVzaX ZpdHksIGl0 IGNvdWxkIH Jlc3VsdCBp biBhIHN1Yn N0YW50aWFs IGRlY2xpbm UgaW4gcmV2 ZW51ZS4gVG hlIGVudHJ5 IG9mIGJpb3 NpbWlsYXJz IGFuZCBnZW 5lcmljcyB0 eXBpY2FsbH kgbGVhZHMg dG8gcHJpY2 UgZXJvc2lv biwgd2hpY2 ggd291bGQg ZnVydGhlci BleGFjZXJi YXRlIHRoZS BkZWNsaW5l IGluIHNhbG VzIGZvciBS b2NoZeKAmX MgZXhpc3Rp bmcgZHJ1Zy Bwb3J0Zm9s aW8uIEZvci BleGFtcGxl LCBpZiBhIG 1ham9yIGNh bmNlciB0cm VhdG1lbnQg ZHJ1ZyBleH BlcmllbmNl cyBhIDUwJS ByZWR1Y3Rp b24gaW4gc2 FsZXMgdm9s dW1lIGR1ZS B0byBuZXcg bWFya2V0IG VudHJhbnRz LCBSb2NoZS BtaWdodCBz ZWUgYSBkcm FtYXRpYyBk cm9wIGluIG l0cyBvdmVy YWxsIHJldm VudWUuPGJy PlRoZSBjb2 1wYW554oCZ cyBtYXJnaW 5zIHdvdWxk IGJlZ2luIH RvIHNocmlu ayBzaWduaW ZpY2FudGx5 IGFzIGEgcm VzdWx0IG9m IHRoaXMgcm V2ZW51ZSBk ZWNsaW5lLi BXaXRoIHRo ZSBsb3dlci BzYWxlcyBw cmljZXMgdG hhdCBjb21l IHdpdGggaW 5jcmVhc2Vk IGNvbXBldG l0aW9uLCBS b2NoZeKAmX MgZ3Jvc3Mg bWFyZ2lucy Bjb3VsZCBk aXAgYmVsb3 cgaW5kdXN0 cnkgc3Rhbm RhcmRzLCBw b3RlbnRpYW xseSBmYWxs aW5nIGZyb2 0gdGhlIGN1 cnJlbnQgNz AlLTgwJSBy YW5nZSB0by Bhcm91bmQg NTAlLTYwJS 4gQWRkaXRp b25hbGx5LC BmaXhlZCBj b3N0cyBmb3 IgcmVzZWFy Y2ggYW5kIG RldmVsb3Bt ZW50LCBtYX JrZXRpbmcs IGFuZCBhZG 1pbmlzdHJh dGl2ZSBleH BlbnNlcyB3 b3VsZCBjb2 50aW51ZSB0 byBleGVydC BwcmVzc3Vy ZSBvbiB0aG UgY29tcGFu eSwgY2F1c2 luZyBvcGVy YXRpbmcgbW FyZ2lucyB0 byBkZWNsaW 5lIGV2ZW4g ZnVydGhlci 48YnI+Q2Fz aCBmbG93IH dvdWxkIGJl IG5lZ2F0aX ZlbHkgYWZm ZWN0ZWQgYX Mgd2VsbC4g V2l0aCByZW R1Y2VkIHJl dmVudWVzLC BSb2NoZeKA mXMgZnJlZS BjYXNoIGZs b3csIHdoaW NoIGlzIGNy dWNpYWwgZm 9yIGZ1bmRp bmcgb25nb2 luZyByZXNl YXJjaCBhbm QgcmV0dXJu aW5nIHZhbH VlIHRvIHNo YXJlaG9sZG VycywgbWln aHQgZGVjcm Vhc2Ugc2hh cnBseS4gVG hlIGNvbXBh bnkgbWF5IH N0cnVnZ2xl IHRvIG1haW 50YWluIGl0 cyBoaXN0b3 JpY2FsIGxl dmVscyBvZi BkaXZpZGVu ZCBwYXlvdX RzIGFuZCBz dG9jayBidX liYWNrcywg bGVhZGluZy B0byBkZWNy ZWFzZWQgaW 52ZXN0b3Ig Y29uZmlkZW 5jZS48YnI+ TGFzdGx5LC BSb2NoZeKA mXMgYmFsYW 5jZSBzaGVl dCBjb3VsZC BkZXRlcmlv cmF0ZSB1bm RlciB0aGlz IHNjZW5hcm lvLiBJZiBj YXNoIGZsb3 cgZGVjbGlu ZXMgYW5kIH RoZSBjb21w YW554oCZcy BhYmlsaXR5 IHRvIGludm VzdCBpbiBu ZXcgZHJ1Z3 MgZGltaW5p c2hlcywgUm 9jaGUgbWln aHQgbmVlZC B0byByZXNv cnQgdG8gZG VidCBmaW5h bmNpbmcgdG 8gc3RhYmls aXplIGl0cy BvcGVyYXRp b25zLiBUaG lzIGNvdWxk IGxlYWQgdG 8gYW4gaW5j cmVhc2UgaW 4gdGhlIGRl YnQtdG8tZX F1aXR5IHJh dGlvLCBhZH ZlcnNlbHkg aW1wYWN0aW 5nIHRoZSBj b21wYW554o CZcyBjcmVk aXQgcmF0aW 5nLiBJZiBk ZWJ0IGxldm VscyByaXNl IHRvbyBoaW doIHdpdGhv dXQgY29ycm VzcG9uZGlu ZyByZXZlbn VlIHRvIHN1 cHBvcnQgaW 50ZXJlc3Qg cGF5bWVudH MsIFJvY2hl IGNvdWxkIG ZpbmQgaXRz ZWxmIGluIG EgcHJlY2Fy aW91cyBwb3 NpdGlvbiwg bGVhZGluZy B0byBwb3Rl bnRpYWwgbG lxdWlkaXR5 IGlzc3Vlcy 48YnI+SW4g c3VtbWFyeS wgdGhpcyBz Y2VuYXJpby B3b3VsZCBs aWtlbHkgcm VzdWx0IGlu IHNpZ25pZm ljYW50bHkg bG93ZXIgcm V2ZW51ZSBh bmQgcHJvZm l0IG1hcmdp bnMsIHJlZH VjZWQgY2Fz aCBmbG93IG FmZmVjdGlu ZyBvcGVyYX Rpb25hbCBm bGV4aWJpbG l0eSwgYW5k IGEgc3RyYW luZWQgYmFs YW5jZSBzaG VldCwgZWFj aCBjb250cm lidXRpbmcg dG8gYSBsb2 5nLXRlcm0g ZGVjbGluZS BpbiBSb2No ZeKAmXMgZW Nvbm9taWMg aGVhbHRoLj xicj4=
Interesting facts about the company
Roche

๐Ÿ“ˆ Want to read more about Roche?

Sign up for free or log in

๐Ÿ’ก Learn smarter stock picks with "The Checklist Value Investor โ€” A Smarter Way to Pick Stocks"

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvV0 96enhFcGNt R2Q4UXlha2 JzNUsud2Vi cCIgYWx0PS JSb2NoZSIg dGl0bGU9Il JvY2hlIiAg Y2xhc3M9Im ltZy1mbHVp ZCIgaGVpZ2 h0PTUwIHdp ZHRoPTUwIG xvYWRpbmc9 J2xhenknIH N0eWxlPSdi b3JkZXItcm FkaXVzOiA2 cHg7Jz4KCi AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nZmxleDog MTsgdGV4dC 1hbGlnbjog Y2VudGVyOy BtYXJnaW4t bGVmdDogNX B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgID xwIHN0eWxl PSdmb250LX NpemU6IDI2 cHg7IGNvbG 9yOiAjMzMz OyBtYXJnaW 4tYm90dG9t OiAxNXB4Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Dwn5OIIFdh bnQgdG8gcm VhZCBtb3Jl IGFib3V0IF JvY2hlPwog ICAgICAgIC AgICAgICAg ICAgICAgIC A8L3A+Cgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8YSBocmVm PSdpbmRleC 5waHA/cGFn ZT1zaWdudX AnIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGJhY2tncm 91bmQtY29s b3I6ICMwMD dCRkY7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBjb2xv cjogI2ZmZj sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH BhZGRpbmc6 IDEwcHggMj BweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJvcmRl ci1yYWRpdX M6IDVweDsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGZvbn Qtd2VpZ2h0 OiBib2xkOw ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgbW FyZ2luLXJp Z2h0OiAxMH B4OwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdHJhbnNp dGlvbjogYm Fja2dyb3Vu ZC1jb2xvci AwLjNzIGVh c2U7JwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgb25tb3 VzZW92ZXI9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA1NmIzIi cKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG 9ubW91c2Vv dXQ9J3RoaX Muc3R5bGUu YmFja2dyb3 VuZENvbG9y PSIjMDA3Qk ZGIic+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBTaWdu IHVwIGZvci BmcmVlCiAg ICAgICAgIC AgICAgICAg ICAgICAgID wvYT4KCiAg ICAgICAgIC AgICAgICAg ICAgICAgID xzcGFuIHN0 eWxlPSdtYX JnaW46IDAg OHB4OyBjb2 xvcjogIzU1 NTsnPm9yPC 9zcGFuPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGEgaHJl Zj0naW5kZX gucGhwP3Bh Z2U9bG9naW 4nIHN0eWxl PScKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGNvbG9yOi AjMDA3QkZG OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg dGV4dC1kZW NvcmF0aW9u OiB1bmRlcm xpbmU7CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBmb250 LXdlaWdodD ogNTAwOyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICBs b2cgaW4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9hPgoKCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxwIHN0eW xlPSdtYXJn aW4tdG9wOi AxNXB4OyBm b250LXNpem U6IDEzcHg7 IGZvbnQtd2 VpZ2h0OiBi b2xkOyBjb2 xvcjogI2Qz MmYyZjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAg8J +TliBHZXQg aW5zaWdodH MgZnJvbSA8 aT4iVGhlIE NoZWNrbGlz dCBWYWx1ZS BJbnZlc3Rv ciDigJQgQS BTbWFydGVy IFdheSB0by BQaWNrIFN0 b2NrcyI8L2 k+IG5vdyEK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9wPgoK ICAgICAgIC AgICAgICAg ICAgICAgIC AgPCEtLQog ICAgICAgIC AgICAgICAg ICAgICAgIC A8ZGl2IHN0 eWxlPSdtYX JnaW4tdG9w OiAxMnB4Oy Bmb250LXNp emU6IDEzcH g7IGNvbG9y OiAjNDQ0Oy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BTaWduIHVw IG5vdyBhbm QgZ2V0IG91 ciBmcmVlIG VCb29rIAog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgPGI+ VGhlIENoZW NrbGlzdCBW YWx1ZSBJbn Zlc3RvciDi gJQgQSBTbW FydGVyIFdh eSB0byBQaW NrIFN0b2Nr czwvYj4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IC0tPgogIC AgICAgICAg ICAgICAgIC AgICAgICA8 IS0tCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxk aXYgc3R5bG U9J21hcmdp bi10b3A6ID E2cHg7IGZv bnQtc2l6ZT ogMTRweDsg Y29sb3I6IC M0NDQ7IGZv bnQtZmFtaW x5OiAtYXBw bGUtc3lzdG VtLCBCbGlu a01hY1N5c3 RlbUZvbnQs IFNlZ29lIF VJLCBSb2Jv dG8sIEhlbH ZldGljYSBO ZXVlLCBzYW 5zLXNlcmlm OyBsaW5lLW hlaWdodDog MS42Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBIYX ZlIHlvdSBo ZWFyZCBhYm 91dCBvdXIg c2hvcnQgPH N0cm9uZyBz dHlsZT0nZm 9udC13ZWln aHQ6IDYwMD snPkRhaWx5 IFZpZGVvIE 5ld3NsZXR0 ZXI8L3N0cm 9uZz4/CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICA8YSBo cmVmPSdodH RwczovL3d3 dy5pbnNpZ2 h0ZnVsdmFs dWUuY29tL2 5ld3NsZXR0 ZXIucGhwJy B0YXJnZXQ9 J19ibGFuay cgc3R5bGU9 J2NvbG9yOi AjMDA3QkZG OyB0ZXh0LW RlY29yYXRp b246IG5vbm U7IGZvbnQt d2VpZ2h0Oi A1MDA7IG1h cmdpbi1sZW Z0OiA2cHg7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBGaW 5kIG91dCBt b3JlCiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICA8L2E+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAgIC AgICAgICAg ICAtLT4KIC AgICAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgCiAg ICAgICAgCi AgICAgICAg PHNwYW4gY2 xhc3M9J2Js dXJyZWQtdG V4dCc+CiAg ICAgICAgIC AgIE1TNGdS bTkxYm0gUm xaQ0JwYmlB eCBPRGsySU dKNUlFIFp5 YVhSNklFaH YgWm1adFlX NXVMVSB4aE lGSnZZMmhs IExDQlNiMk 5vWlMgQnBj eUJoSUZOMy BhWE56SUcx MWJIIFJwYm 1GMGFXOXUg WVd3Z2FHVm hiSCBSb1ky RnlaU0JqIG IyMXdZVzU1 SUggUm9ZWF FnYjNCbCBj bUYwWlhNZ2 FXIDRnYjNa bGNpQXggTU RBZ1kyOTFi biBSeWFXVn pJSGR2IGNt eGtkMmxrWl MgNDhZbkkr TWk0ZyBVbT lqYUdVZ2FY IE1nZEdobE lIZHYgY214 azRvQ1pjeS BCc1lYSm5a WE4wIElHSn BiM1JsWTIg Z2dZMjl0Y0 dGdSBlU0Jo Ym1RZ2FYIE 1nWVNCc1pX RmsgWlhJZ2 FXNGdkRyBo bElHWnBaV3 hrIElHOW1J SEJsY24gTn ZibUZzYVhw bCBaQ0JvWl dGc2RHIGhq WVhKbExDQj MgYUdsamFD Qm1iMiBOMW MyVnpJRzl1 IElHUmxkbV ZzYjMgQnBi bWNnZEdGcC BiRzl5WldR Z2RIIEpsWV hSdFpXNTAg Y3lCbWIzSW djRyBGMGFX VnVkSE1nIF ltRnpaV1Fn YjIgNGdkR2 hsYVhJZyBh VzVrYVhacF pIIFZoYkNC blpXNWwgZE dsaklHMWhh MiBWMWNDND hZbkkrIE15 NGdVbTlqYU cgVWdhR0Z6 SUdFZyBhR2 x6ZEc5eWVT IEJ2WmlCa1 pYWmwgYkc5 d2FXNW5JRy BkeWIzVnVa R0p5IFpXRn JhVzVuSUcg MWxaR2xqYV c1bCBjeUJo Ym1RZ1pHIG xoWjI1dmMz UnAgWTNNc0 lHbHVZMiB4 MVpHbHVaeU IwIGFHVWda bWx5YzMgUW dZVzUwYVdK cCBiM1JwWX lBb2NHIFZ1 YVdOcGJHeH AgYmlrc0lI Um9aUyBCbW FYSnpkQ0Jo IGJuUnBjbV YwY20gOTJh WEpoYkNCMC BjbVZoZEcx bGJuIFFnWm 05eUlFaEog Vmk5QlNVUl RMQyBCaGJt UWdkR2hsIE lHWnBjbk4w SUggUnlaV0 YwYldWdSBk Q0JtYjNJZ2 FHIFZ3WVhS cGRHbHogSU VNdVBHSnlQ aiBRdUlGUm 9aU0JqIGIy MXdZVzU1SU cgbHVkbVZ6 ZEhNZyBhR1 ZoZG1sc2VT IEJwYmlCeV pYTmwgWVhK amFDQmhibS BRZ1pHVjJa V3h2IGNHMW xiblFzSUgg ZHBkR2dnYj NabCBjaUFr TVRJZ1ltIG xzYkdsdmJp QnogY0dWdW RDQnBiaSBB eU1ESXdJR0 ZzIGIyNWxM aUJKZEMgQm hiSE52SUhC aCBjblJ1Wl hKeklIIGRw ZEdnZ1lTQj MgYVdSbElI SmhibSBkbE lHOW1JR0Zq IFlXUmxiV2 xqSUcgbHVj M1JwZEhWMC BhVzl1Y3lC aGJtIFFnWW 1sdmRHVmog YUNCamIyMX dZVyA1cFpY TWdkRzhnIF lXUjJZVzVq WlMgQm9aV0 ZzZEdoaiBZ WEpsSUdsdW JtIDkyWVhS cGIyNHUgUE dKeVBqVXVJ RiBKdlkyaG xJR2hoIGN5 QmhJR1JwZG 0gVnljMlVn Y0c5eSBkR1 p2YkdsdklH IDltSUhCeW IyUjEgWTNS ekxDQnBibS BOc2RXUnBi bWNnIFltOT BhQ0J3Y20g VnpZM0pwY0 hScCBiMjRn WkhKMVozIE 1nWVc1a0lH UnAgWVdkdW IzTjBhVyBN Z2RHVnpkSE 11IElFbDBj eUJ0WVcgbH VJR0Z5WldG eiBJRzltSU dadlkzIFZ6 SUdsdVkyeD EgWkdVZ2Iy NWpiMiB4dl oza3NJR2x0 IGJYVnViMn h2WjMga3NJ R0Z1WkNCdS BaWFZ5YjNO amFXIFZ1WT JVdVBHSnkg UGpZdUlGUm 9aUyBCamIy MXdZVzU1IE lIQnNZV05s Y3kgQmhJSE 4wY205dSBa eUJsYlhCb1 lYIE5wY3lC dmJpQnogZF hOMFlXbHVZ VyBKcGJHbD BlU0JoIGJt UWdhR0Z6SU ggTmxkQ0Jo YldKcCBkR2 x2ZFhNZ1oy IDloYkhNZ2 RHOGcgY21W a2RXTmxJRy BsMGN5Qmxi blpwIGNtOX ViV1Z1ZEcg RnNJR2x0Y0 dGaiBkQ0Jo Ym1RZ2FXID VqY21WaGMy VWcgWVdOal pYTnpJSCBS dklHaGxZV3 gwIGFHTmhj bVVnYVcgNG dkVzVrWlhK eiBaWEoyWl dRZ1kyIDl0 YlhWdWFYUn AgWlhNdVBH SnlQaiBjdU lGSnZZMmhs IElHaGhjeU JoSUggTnBa MjVwWm1sai BZVzUwSUhC eVpYIE5sYm 1ObElHbHUg SUhSb1pTQl ZibSBsMFpX UWdVM1JoIG RHVnpMQ0Iz YVggUm9JR2 wwY3lCTyBi M0owYUNCQm JXIFZ5YVdO aGJpQm8gWl dGa2NYVmhj biBSbGNuTW diRzlqIFlY UmxaQ0JwYm kgQkpibVJw WVc1aCBjRz lzYVhNc0lF IGx1WkdsaG JtRXUgUEdK eVBqZ3VJRS BsdUlESXdN VGtzIElGSn ZZMmhsSUgg SmhibXRsWk NCaCBjeUIw YUdVZ05IIF JvSUcxdmMz UWcgYzNWem RHRnBibSBG aWJHVWdZMj l0IGNHRnVl U0JwYmkgQj BhR1VnZDI5 eSBiR1FnWW 5rZ1EyIDl5 Y0c5eVlYUm wgSUV0dWFX ZG9kSCBNdV BHSnlQamt1 IElGUm9aU0 JqYjIgMXdZ VzU1NG9DWi BjeUJ6ZVcx aWIyIHdzSU hSb1pTQm8g WlhoaFoyOX VZVyB3Z1Vt OWphR1VnIG JHOW5ieXdn Y20gVndjbV Z6Wlc1MCBj eUIwYUdVZ2 MyIGw0SUdO b1pXMXAgWT JGc0lHVnNa VyAxbGJuUn pJR1Z6IGMy VnVkR2xoYk MgQm1iM0ln YkdsbSBaVG 9nWTJGeVlt IDl1TENCb2 VXUnkgYjJk bGJpd2dibS BsMGNtOW5a VzRzIElHOT RlV2RsYmkg d2djR2h2Yz NCbyBiM0ox Y3l3Z1lXID VrSUhOMWJH WjEgY2k0OF luSStNVCBB dUlGSnZZMm hsIElHbHpJ R052YlcgMX BkSFJsWkNC MCBieUJrYV habGNuIE5w ZEhrZ1lXNW sgSUdsdVky eDFjMiBsdm Jpd2dkMmww IGFDQmhJSG R2Y20gdG1i M0pqWlNCMC BhR0YwSUds dVkyIHgxWk dWeklHVnQg Y0d4dmVXVm xjeSBCbWNt OXRJRzkyIF pYSWdNVFV3 SUcgUnBabV psY21WdSBk Q0J1WVhScG IyIDVoYkds MGFXVnogSU dGdVpDQmhJ RyBkdllXd2 dkRzhnIFlX Tm9hV1YyWl MgQm5aVzVr WlhJZyBZbU ZzWVc1alpT IEJwYmlCc1 pXRmsgWlhK emFHbHdJSC BCdmMybDBh Vzl1IGN5ND 0KICAgICAg ICA8L3NwYW 4+CiAgICAg ICAgCiAgIC AgICAg
See Company Q&A
Roche

๐Ÿ“Š Get full analytics about Roche

Sign up for free or log in

โœ๏ธ Sign up to get "The Checklist Value Investor โ€” A Smarter Way to Pick Stocks" for free

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal